MOLECULAR MECHANISMS OF MULTIDRUG RESISTANCE OVERCOMING BY LIPOSOMAL ANTITUMOR DRUGS
- Authors: Baryshnikova M.A.1, Baryshnikov A.Y.1, Afanasieva D.A.1
-
Affiliations:
- FSBSI «N.N. Blokhin RCRC», Moscow
- Issue: Vol 14, No 1 (2015)
- Pages: 3-10
- Section: REVIEW
- Published: 30.03.2015
- URL: https://bioterapevt.abvpress.ru/jour/article/view/2
- DOI: https://doi.org/10.17650/1726-9784-2015-14-1-3-10
- ID: 2
Cite item
Abstract
The liposomal antitumor drugs cell death induction mechanism has been analyzed in this work. Liposomal dosage forms of doxorubicin, cisplatin and aranosa overcome drug resistance. However, the mechanism of overcoming drug resistance by this drugs is different. Liposomal doxorubicin overcomes multidrug resistance by liposomes binding with the P-glycoprotein in 185 position of glycine. Liposomal cisplatin overcomes monoresistance by external apoptosis gene activation. The liposomal aranosa does not use CD95/Fas signaling pathway of apoptosis. Thus, liposomal drug action mechanism depends on the type of cells, and on the antitumor drug, that is enclosed in a liposome and can be individualized in each case.
About the authors
M. A. Baryshnikova
FSBSI «N.N. Blokhin RCRC», Moscow
Author for correspondence.
Email: ma_ba@mail.ru
Russian Federation
A. Yu. Baryshnikov
FSBSI «N.N. Blokhin RCRC», MoscowRussian Federation
D. A. Afanasieva
FSBSI «N.N. Blokhin RCRC», MoscowRussian Federation
References
Supplementary files

